J
Joerg Hennenlotter
Researcher at University of Tübingen
Publications - 114
Citations - 2122
Joerg Hennenlotter is an academic researcher from University of Tübingen. The author has contributed to research in topics: Bladder cancer & Renal cell carcinoma. The author has an hindex of 21, co-authored 114 publications receiving 1916 citations.
Papers
More filters
Journal ArticleDOI
Economic aspects of bladder cancer: what are the benefits and costs?
Karl-Dietrich Sievert,Bastian Amend,Udo Nagele,David Schilling,Jens Bedke,M. Horstmann,Joerg Hennenlotter,S. Kruck,Arnulf Stenzl +8 more
TL;DR: New diagnostic tools such as urine markers may assist in more cost-effectively detecting BC at an earlier stage, however, these markers cannot replace the cystoscopy, which is the current standard of care.
Journal ArticleDOI
MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.
Aristotelis G. Anastasiadis,M. P. Lichy,Udo Nagele,Markus Kuczyk,Axel S. Merseburger,Joerg Hennenlotter,S. Corvin,Karl-Dietrich Sievert,Claus D. Claussen,Arnulf Stenzl,Heinz Peter Schlemmer +10 more
TL;DR: The method is safe, can be useful to select suspicious areas in the prostate, and has the potential to improve cancer detection rate in men with previous negative TRUS-biopsies.
Journal ArticleDOI
Expansion and differentiation of neural progenitors derived from the human adult enteric nervous system.
Marco Metzger,Petra M. Bareiss,Timm Danker,Silvia Wagner,Joerg Hennenlotter,Elke Guenther,Florian Obermayr,Arnulf Stenzl,Alfred Koenigsrainer,Thomas Skutella,Lothar Just +10 more
TL;DR: It is feasible to isolate and expand enteric progenitor cells from human adult tissue and these findings offer new strategies for enteric stem cell research and future cell-based therapies.
Journal ArticleDOI
DNA Methylation of the SLC16A3 Promoter Regulates Expression of the Human Lactate Transporter MCT4 in Renal Cancer with Consequences for Clinical Outcome
Pascale Fisel,Stephan Kruck,Stefan Winter,Jens Bedke,Joerg Hennenlotter,Anne T. Nies,Marcus Scharpf,Falko Fend,Arnulf Stenzl,Matthias Schwab,Elke Schaeffeler +10 more
TL;DR: SLC16A3 promoter DNA methylation was identified as a novel epigenetic mechanism for MCT4 regulation in ccRCC with first evidence of a biological rationale for prognosis and clinical outcome.
Journal ArticleDOI
Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma.
Kai Gebauer,Inga Peters,Natalia Dubrowinskaja,Joerg Hennenlotter,Mahmoud Abbas,Ralph Scherer,Hossein Tezval,Axel S. Merseburger,A. Stenzl,M.A. Kuczyk,Jürgen Serth +10 more
TL;DR: Tumour-specific hypermethylation of mir-124-3 in samples of RCCs with clear cell histology (ccRCC) compared with paired normal appearing tissues was found and was identified as a relevant epigenetic mark for ccRCC thus underlining the need for functional studies of potentially affected signalling pathways in kidney tumour models.